13-48037782-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_018283.4(NUDT15):āc.36A>Cā(p.Pro12Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00161 in 1,587,332 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.0019 ( 4 hom., cov: 33)
Exomes š: 0.0016 ( 9 hom. )
Consequence
NUDT15
NM_018283.4 synonymous
NM_018283.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.64
Genes affected
NUDT15 (HGNC:23063): (nudix hydrolase 15) This gene encodes an enzyme that belongs to the Nudix hydrolase superfamily. Members of this superfamily catalyze the hydrolysis of nucleoside diphosphates, including substrates like 8-oxo-dGTP, which are a result of oxidative damage, and can induce base mispairing during DNA replication, causing transversions. The encoded enzyme is a negative regulator of thiopurine activation and toxicity. Mutations in this gene result in poor metabolism of thiopurines, and are associated with thiopurine-induced early leukopenia. Multiple pseudogenes of this gene have been identified. [provided by RefSeq, Apr 2016]
SUCLA2 (HGNC:11448): (succinate-CoA ligase ADP-forming subunit beta) Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.2).
BP6
Variant 13-48037782-A-C is Benign according to our data. Variant chr13-48037782-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 3234192.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-4.64 with no splicing effect.
BS2
High AC in GnomAd4 at 295 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUDT15 | NM_018283.4 | c.36A>C | p.Pro12Pro | synonymous_variant | 1/3 | ENST00000258662.3 | NP_060753.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUDT15 | ENST00000258662.3 | c.36A>C | p.Pro12Pro | synonymous_variant | 1/3 | 1 | NM_018283.4 | ENSP00000258662.1 | ||
SUCLA2 | ENST00000646804.1 | c.-261T>G | 5_prime_UTR_variant | 1/11 | ENSP00000493977.1 | |||||
SUCLA2 | ENST00000643246.1 | c.-339T>G | 5_prime_UTR_variant | 1/3 | ENSP00000496235.1 |
Frequencies
GnomAD3 genomes AF: 0.00194 AC: 295AN: 152174Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
295
AN:
152174
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00151 AC: 306AN: 202908Hom.: 0 AF XY: 0.00154 AC XY: 168AN XY: 109212
GnomAD3 exomes
AF:
AC:
306
AN:
202908
Hom.:
AF XY:
AC XY:
168
AN XY:
109212
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00157 AC: 2258AN: 1435040Hom.: 9 Cov.: 31 AF XY: 0.00161 AC XY: 1148AN XY: 711130
GnomAD4 exome
AF:
AC:
2258
AN:
1435040
Hom.:
Cov.:
31
AF XY:
AC XY:
1148
AN XY:
711130
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00194 AC: 295AN: 152292Hom.: 4 Cov.: 33 AF XY: 0.00195 AC XY: 145AN XY: 74462
GnomAD4 genome
AF:
AC:
295
AN:
152292
Hom.:
Cov.:
33
AF XY:
AC XY:
145
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2024 | NUDT15: BP4, BP7, BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at